Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis—is it time to consider a new radiotracer?

Georgios Christopoulos; Panithaya Chareonthaitawee

doi:10.1186/s13550-017-0322-z

Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis—is it time to consider a new radiotracer?

Georgios Christopoulos, Panithaya Chareonthaitawee

Cardiovascular Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	70
Journal	EJNMMI Research
Volume	7
DOIs	https://doi.org/10.1186/s13550-017-0322-z
State	Published - 2017

Keywords

Fluorine-18 fluorodeoxyglucose
Fluorine-18 fluorothymidine
Positron emission tomography
Radiotracers
Sarcoidosis

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1186/s13550-017-0322-z

Cite this

@article{63be5878caff4f2f8d407a649c00bfc9,

title = "Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis—is it time to consider a new radiotracer?",

keywords = "Fluorine-18 fluorodeoxyglucose, Fluorine-18 fluorothymidine, Positron emission tomography, Radiotracers, Sarcoidosis",

author = "Georgios Christopoulos and Panithaya Chareonthaitawee",

year = "2017",

doi = "10.1186/s13550-017-0322-z",

language = "English (US)",

volume = "7",

journal = "EJNMMI Research",